This content is in French.
Breast cancer: a decade that transformed treatment
2 octobre 2026
Over the past
decade, breast cancer management has undergone profound changes. The
introduction of CDK4/6 inhibitors, therapies targeting the PI3K/AKT/mTOR
pathway, new anti-HER2 treatments, immunotherapy, and antibody–drug conjugates
(ADCs) has progressively shifted treatment toward an approach guided by the
molecular characteristics of each tumor.
A review
published in Cancers in 2026 looks back at this decade of innovation and
examines the major clinical trials and molecular advances that have shaped this
evolution.
Sign in to read the rest
Reserved for healthcare professionals, free registration.
Scientific reference
Dynarowicz K, Bartusik-Aebisher D, Czech S, Kawczyk-Krupka A, Aebisher D. A Decade of Innovation in Breast Cancer (2015–2025): A Comprehensive Review of Clinical Trials, Targeted Therapies and Molecular Perspectives. Cancers. 2026;18:361.
